Clinical Trials · NCT01161563
Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Watson Pharmaceuticals
- Enrollment
- 118
- Start date
- Jul 2010
- Locations
- 16 sites, United States
- Primary endpoint
- Patient Bother From Injection Site Burning and/or Stinging